13063_2017_1812_MOESM5_ESM.pdf (190.84 kB)

Additional file 5: of Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial

Download (190.84 kB)
journal contribution
posted on 07.03.2017, 05:00 by Amy Cranston, Deborah Stocken, Elaine Stamp, David Roblin, Julia Hamlin, James Langtry, Ruth Plummer, Alan Ashworth, John Burn, Neil Rajan
SPIRIT figure showing schedule of events in cohort 1 of the trial. (PDF 140 kb)


Health Innovation Challenge Fund, Wellcome Trust and Department of Health